Literature DB >> 1437431

Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome.

F J Walther1, M J Benders, J O Leighton.   

Abstract

Cardiac catheterization studies have demonstrated that Doppler-derived flow velocities in the ductal flow jet and the left pulmonary artery accurately predict the aortopulmonary pressure difference and left-to-right shunt size in newborns. To assess the presence of persistent pulmonary hypertension in premature newborns with various degrees of respiratory distress syndrome (RDS) severity, we estimated pulmonary artery pressure from the aortopulmonary pressure difference and pulmonary blood flow from the left pulmonary artery flow velocity with color-flow-directed, pulsed Doppler echocardiography. Seventy-nine premature neonates were divided into three groups--no or mild RDS (n = 27), severe RDS (n = 38), and fatal RDS (n = 14)--and compared with a group of healthy term neonates (n = 34). In premature and term neonates with no/mild RDS the mean +/- SEM aortopulmonary pressure difference increased from 7.3 +/- 0.4 and 6.6 +/- 0.5 mm Hg to 22.8 +/- 1.4 and 21.4 +/- 1.1 mm Hg over the first 24 hours (P < .001). The mean aortopulmonary pressure difference was 0.9 +/- 0.3 mm Hg during the first 72 hours in neonates with fatal RDS, but increased from 1.5 +/- 0.3 mm Hg at 4 hours to 7.4 +/- 0.6 at 24 hours and 21.5 +/- 0.7 mm Hg at 72 hours of age in neonates with severe RDS. Left pulmonary artery velocity time integrals were 18.3 +/- 0.5 cm in premature and 18.8 +/- 0.5 cm in term neonates with no/mild RDS at 12 hours vs 11.2 +/- 0.4 cm in neonates with severe and 9.9 +/- 0.5 cm in neonates with fatal RDS (P < .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1437431

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  29 in total

Review 1.  Monitoring cardiovascular function in infants with chronic lung disease of prematurity.

Authors:  S H Abman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

2.  Measurement of right ventricular volume in healthy term and preterm neonates.

Authors:  S J Clark; C W Yoxall; N V Subhedar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

3.  Right ventricular volume measurements in ventilated preterm neonates.

Authors:  S J Clark; C W Yoxall; N V Subhedar
Journal:  Pediatr Cardiol       Date:  2004-01-08       Impact factor: 1.655

4.  Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome.

Authors:  J R Skinner; S Hunter; E N Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 5.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

Review 6.  The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure.

Authors:  A T Dinh-Xuan; F Brunet; J F Dhainaut
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

7.  Changes in alveolar-arterial oxygen difference and oxygenation index during low-dose nitric oxide inhalation in 15 newborns with severe respiratory insufficiency.

Authors:  Z Stranák; V Zábrodský; J Simák
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

8.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

9.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

Authors:  Praveen Chandrasekharan; Rafal Kozielski; Vasantha H S Kumar; Munmun Rawat; Veena Manja; Changxing Ma; Satyan Lakshminrusimha
Journal:  Am J Perinatol       Date:  2016-09-14       Impact factor: 1.862

Review 10.  Persistent pulmonary hypertension of the newborn.

Authors:  Ru-Jeng Teng; Tzong-Jin Wu
Journal:  J Formos Med Assoc       Date:  2013-01-03       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.